Unicoat Pharma ApS: Financial statements 2021
CVR: 37166707
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Unicoat Pharma ApS (CVR 37166707) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 689,144 and a net result of DKK 535,241 compared with DKK 632,016 the year before. That is a decrease of 46.8% compared with the year before. Equity in the 2021 report amounted to DKK 289,740. The solvency ratio was 25.1%.
- Gross Profit
- DKK 689,144
- Profit/Loss
- DKK 535,241
- Equity
- DKK 289,740
- Total Assets
- DKK 1,155,187
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 689 t. | 535 t. | 290 t. | - |
| 2020 | - | 1.3 mio. | 632 t. | 144 t. | - |
| 2019 | - | 648 t. | 523 t. | 712 t. | - |
| 2018 | - | 449 t. | 362 t. | 490 t. | - |
| 2017 | - | 431 t. | 344 t. | 428 t. | - |
Official annual report
Find more companies like Unicoat Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of November 9, 2021, DP Hillerød P/S has been appointed auditor of Unicoat Pharma ApS.
As of November 9, 2021, Revisionsfirmaet P Døssing I/S has stepped down as auditor of Unicoat Pharma ApS.
Unicoat Pharma ApS has published its annual report for 2020. Gross profit came to DKK 1,294,284, and the net result was DKK 632,016.
About Unicoat Pharma ApS
Unicoat Pharma ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2015. The company is registered under the industry Overfladebehandling af metal. The management consists of Morten Clausen, Amanda Ryberg and Magnus Knorr Clausen. The company is owned by M C Holding ApS, MCVA Holding ApS and A Ryberg Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 867,952 and a net result of DKK 680,181 compared with DKK 638,057 the year before. Equity in the 2025 report amounted to DKK 507,241.